News from the Editors -- MEDICA - World Forum for Medicine

MEDICA Newsletter

Social Media

More about…

Image: Ben Larimer and Anna Sorace; Copyright: UAB

Hypoxia imaging and combination therapy aid immunotherapy treatment of solid tumors

29/10/2021

Immunotherapy using checkpoint inhibitors can work well to treat cancer, but only a minority of patients respond to therapy. Researchers at the University of Alabama at Birmingham have now shown — in preclinical experiments — how to identify non-responding tumors and improve their response to immunotherapy, as shown by limited tumor growth and extended survival.
Read more
Image: OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial intelligence); Copyright: OPTIMA

OPTIMA aims to improve treatment for prostate, breast and lung cancer through AI

12/10/2021

The Innovative Medicines Initiative (IMI) – a joint undertaking of the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA) – announced the launch of OPTIMA, a € 21.3 million public-private research programme that will seek to use artificial intelligence (AI) to improve care for patients with prostate, breast and lung cancer.
Read more
Image: Karolinska Institutet researchers Johan Hartman (left), Mattias Rantalainen and Yinxi Wang (right).  ; Copyright: Stefan Zimmerman.

AI improves precision in breast cancer diagnosis

01/10/2021

Researchers have developed an AI-based tool that improves the diagnosis of breast cancer tumours and the ability to predict the risk of recurrence. The greater diagnostic precision can lead to more personalised treatment for the large group of breast cancer patients with intermediate risk tumours. The results are published in the scientific journal Annals of Oncology.
Read more
Image: yellow tape measure with capsules in front of it; Copyright: panthermedia.net/Jiri Hera

Personalized cancer medicine: customized treatment

01/03/2018

Everyone is different. This statement also applies to our health. Cancer, in particular, can look and progress differently depending on the individual person. That’s why every patient ideally also needs a customized treatment that is tailored to their individual needs. But how feasible is this idea?
Read more